Identification and validation of DOCK4 as a potential biomarker for risk of bone metastasis development in patients with early breast cancer

In conclusion, high DOCK4 in early breast cancer is significantly associated with aggressive disease and with future bone metastasis and is a potentially useful biomarker for subsequent bone metastasis risk.This article is protected by copyright. All rights reserved.

Source: The Journal of Pathology - November 14, 2018 Category: Pathology Authors: Jules A. Westbrook, Steven L. Wood, David A. Cairns, Kathryn McMahon, Renu Gahlaut, Helene Thygesen, Mike Shires, Stephanie Roberts, Helen Marshall, Maria R. Oliva, Mark J. Dunning, Andrew M. Hanby, Peter J. Selby, Valerie Speirs, Georgia Ma Tags: Original Paper Source Type: research